| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 390.62× | 390.62× | 333.87× | 302.02× | 291.80× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.70× | 0.65× | 0.76× | 0.77× | 0.88× | ||
| 0.28× | 0.28× | 0.31× | 0.30× | 0.30× | ||
| 0.02× | 0.02× | 0.20× | −1.56× | 1.45× | ||
| 0.02× | 0.02× | 0.18× | −1.35× | 1.36× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 291.80 | 302.02 | 333.87 | 390.62 | 390.62 | |
| Working Capital Turnover | 0.88 | 0.77 | 0.76 | 0.65 | 0.70 | |
| Asset Turnover | 0.30 | 0.30 | 0.31 | 0.28 | 0.28 | |
| Cash Conversion (CFO/Net Income) | 1.45 | -1.56 | 0.20 | 0.02 | 0.02 | |
| CFO/EBITDA | 1.36 | -1.35 | 0.18 | 0.02 | 0.02 |